Therapeutic compositions and methods for inhibiting il-8-mediated inflammation

摘要

Therapeutic compositions of an IL-8 inactivating agent having the activity of C5a serine protease and methods for inhibiting IL-8-mediated inflammation in patients are described. Also described are diagnostic assays and kits for the detection of an IL-8 inactivating agent having the required activity.